| Notation | Type |
|---|
| Adult | MESH |
| Antineoplastic Combined Chemotherapy Protocols/therapeutic use | MESH |
| Busulfan/adverse effects | MESH |
| Carcinoma in Situ/pathology | MESH |
| Cyclophosphamide/adverse effects | MESH |
| Cytarabine/administration & dosage | MESH |
| Daunorubicin/administration & dosage | MESH |
| Diagnosis, Differential | MESH |
| Female | MESH |
| Hematopoietic Stem Cell Mobilization | MESH |
| Hematopoietic Stem Cell Transplantation | MESH |
| Humans | MESH |
| Leukemia, Monocytic, Acute/therapy | MESH |
| Mitoxantrone/administration & dosage | MESH |
| Remission Induction | MESH |
| Thioguanine/administration & dosage | MESH |
| Transplantation, Autologous | MESH |
| Uterine Cervical Dysplasia/pathology | MESH |